Reducing Readmissions for Congestive Heart Failure
... and cardiac events and an improved quality of life.25 Deconditioning may occur in any chronic illness but can be minimized with an appropriate exercise program.26 Reevaluation by a cardiologist following hospitalization is reasonable for patients with class III or IV heart failure. Several studies h ...
... and cardiac events and an improved quality of life.25 Deconditioning may occur in any chronic illness but can be minimized with an appropriate exercise program.26 Reevaluation by a cardiologist following hospitalization is reasonable for patients with class III or IV heart failure. Several studies h ...
The T wave: physiology and pathophysiology Meijborg, VMF
... repolarization phase. In contrast to depolarization, repolarization is a relatively slow process and leads to smaller potential differences over larger distances.4 In addition, the contribution of cellular coupling in reducing the potential differences is larger during repolarization than during dep ...
... repolarization phase. In contrast to depolarization, repolarization is a relatively slow process and leads to smaller potential differences over larger distances.4 In addition, the contribution of cellular coupling in reducing the potential differences is larger during repolarization than during dep ...
Tall R waves in leads V1 to V3
... Figure 2. Anteroposterior chest radiograph showing eventration of the left hemidiaphragm. Much of the gut is at the level of the heart and pushes it toward the right side of the chest. ...
... Figure 2. Anteroposterior chest radiograph showing eventration of the left hemidiaphragm. Much of the gut is at the level of the heart and pushes it toward the right side of the chest. ...
Cardiovascular 22 – Heart Valve Disease
... Echocardiogram – shows left atrial and ventricular dilation. Cardiac catheterisation – blood is seen regurgitating from LV to LA. TREATMENT Continuous monitoring with echocardiogram when sufficiently severe, surgical intervention by valve repair or replacement may be necessary. Mitral Valve Pr ...
... Echocardiogram – shows left atrial and ventricular dilation. Cardiac catheterisation – blood is seen regurgitating from LV to LA. TREATMENT Continuous monitoring with echocardiogram when sufficiently severe, surgical intervention by valve repair or replacement may be necessary. Mitral Valve Pr ...
- The Annals of Thoracic Surgery
... Hemangioma is a benign proliferative lesion characterized by increased endothelial cell turnover. It can be found anywhere in the body, but most frequently it is localized to the cervicofacial region [2]. It can be superficial, deep, or visceral in location. Visceral hemangiomas are frequently locat ...
... Hemangioma is a benign proliferative lesion characterized by increased endothelial cell turnover. It can be found anywhere in the body, but most frequently it is localized to the cervicofacial region [2]. It can be superficial, deep, or visceral in location. Visceral hemangiomas are frequently locat ...
HPI - iupui
... research into the pathophysiology of hypertrophic cardiomyopathy (HOCM). It is characterized by an abnormal arrangement of the myocardial cells, which instead of lying in parallel rows, form whorl-like patterns. It most commonly affects the interventricular septum, but may also involve the entire my ...
... research into the pathophysiology of hypertrophic cardiomyopathy (HOCM). It is characterized by an abnormal arrangement of the myocardial cells, which instead of lying in parallel rows, form whorl-like patterns. It most commonly affects the interventricular septum, but may also involve the entire my ...
Hypertrophic Cardiomyopathy
... • impaired ventricular filling due to an abnormally stiff (rigid) ventricle •normal systolic function (early on in disease) •intraventricular pressure rises precipitously with small increases in volume ...
... • impaired ventricular filling due to an abnormally stiff (rigid) ventricle •normal systolic function (early on in disease) •intraventricular pressure rises precipitously with small increases in volume ...
Eur Heart J Cardiovasc Imaging-2014-Galderisi-ehjci-jeu022
... because of ascertained or suspected coronary artery disease. Each laboratory will be requested to recruit patients with and without heart failure (according to the 2012 ESC guidelines),21 and their history and clinical status at the time of enrolment will be recorded. Each laboratory will be request ...
... because of ascertained or suspected coronary artery disease. Each laboratory will be requested to recruit patients with and without heart failure (according to the 2012 ESC guidelines),21 and their history and clinical status at the time of enrolment will be recorded. Each laboratory will be request ...
EKG made easy
... ECG paper is a grid where time is measured along the horizontal axis moving from left to right Each small square is 1mm in length and represents 0.04 seconds Each larger square is 5mm in length and represents 0.20 seconds ...
... ECG paper is a grid where time is measured along the horizontal axis moving from left to right Each small square is 1mm in length and represents 0.04 seconds Each larger square is 5mm in length and represents 0.20 seconds ...
Safety profile of biweekly schedule of liposomal Doxorubicin (Caelyx
... • There was no evidence of cardiotoxicity in dogs treated with PLD (0.25-1 mg/kg) 1-5 weeks after treatment1, while mild ...
... • There was no evidence of cardiotoxicity in dogs treated with PLD (0.25-1 mg/kg) 1-5 weeks after treatment1, while mild ...
01. CVS,angina, MI & HTN. 2010
... a total occlusion. In unstable angina, acute subendocardial infarction, or sudden cardiac death, the extent of luminal obstruction by thrombosis is usually ...
... a total occlusion. In unstable angina, acute subendocardial infarction, or sudden cardiac death, the extent of luminal obstruction by thrombosis is usually ...
POSSIBLE CARDIO-PROTECTIVE EFFECTS OF TELMISARTAN AGAINIST 5-FLUOROURACIL-
... cases of 5-FU cardiotoxicity. Animal studies have shown both pericarditis and myocarditis in rats following 5-FU infusion. Kumar et al postulated that 5-FU-induced endothelial damage leading to extravasation of 5-FU-containing blood into the myocardium could result in an inflammatory reaction. In ad ...
... cases of 5-FU cardiotoxicity. Animal studies have shown both pericarditis and myocarditis in rats following 5-FU infusion. Kumar et al postulated that 5-FU-induced endothelial damage leading to extravasation of 5-FU-containing blood into the myocardium could result in an inflammatory reaction. In ad ...
The Second Heart Sound (S2) Chapter 8
... • Caused by the vibration created in the ventricles as they expand in the second phase of rapid diastolic filling when the atria contract and before the first heart sound • Fourth heart sounds seldom occur in normal hearts • Pathological S4 is a low-frequency, dull or thudding sound resulting from t ...
... • Caused by the vibration created in the ventricles as they expand in the second phase of rapid diastolic filling when the atria contract and before the first heart sound • Fourth heart sounds seldom occur in normal hearts • Pathological S4 is a low-frequency, dull or thudding sound resulting from t ...
Patient Medication Adherence and Physician Prescribing among
... ACEI and ARB add up to 84% which was marginally higher than other studies (61.7 to 82%)[28]. Guidelines recommend the routine use of ACEI or ARB, and beta blockers in heart failure patients due to their proven improvement in morbidity, mortality and hospitalisation rates [1] . Our study indicates th ...
... ACEI and ARB add up to 84% which was marginally higher than other studies (61.7 to 82%)[28]. Guidelines recommend the routine use of ACEI or ARB, and beta blockers in heart failure patients due to their proven improvement in morbidity, mortality and hospitalisation rates [1] . Our study indicates th ...
Chapter 19 Heart
... 1. great cardiac vein 2. middle cardiac vein - both empty into coronary sinus in right atrium V. Cardiac cycle The actual physical contraction pattern of the myocardium as determined by the conduction The two atria are in systole and diastole together as are the two ventricles A. Contraction is syst ...
... 1. great cardiac vein 2. middle cardiac vein - both empty into coronary sinus in right atrium V. Cardiac cycle The actual physical contraction pattern of the myocardium as determined by the conduction The two atria are in systole and diastole together as are the two ventricles A. Contraction is syst ...
2. The arrhythmias with heterotop automatism predominance are the
... B. P-R interval shorter than that of basic rhythm C. QRS complexes is supple, by supraventricular type D. QRS complex is opposed to T waves in standard leads E. P wave is sharp, biphasic or negative 4. Atrioventricular extrasystole on ECG is characterizing by follows, except: A. P wave is negative, ...
... B. P-R interval shorter than that of basic rhythm C. QRS complexes is supple, by supraventricular type D. QRS complex is opposed to T waves in standard leads E. P wave is sharp, biphasic or negative 4. Atrioventricular extrasystole on ECG is characterizing by follows, except: A. P wave is negative, ...
PACE 25: 1000, 2002
... the benefit/risk balance. (Evidence level B) 3. AV junction : Ablation of the AV junction with subsequent complete heart block should be recommended for those patients with atrial tachycardias, particularly persistent or permanent atrial fibrillation in which the ventricular response rate cannot be ...
... the benefit/risk balance. (Evidence level B) 3. AV junction : Ablation of the AV junction with subsequent complete heart block should be recommended for those patients with atrial tachycardias, particularly persistent or permanent atrial fibrillation in which the ventricular response rate cannot be ...
Pregnancy Management Guidelines in Women with Cardiac Diseases
... congenital heart disease have increased the survival rate of children affected with these disorders. Pregnant women who have congenital heart disease represent the largest number of patients seen at some referral centers, comprising as many as 70% to 80% of all the cardiac patients. It is estimated ...
... congenital heart disease have increased the survival rate of children affected with these disorders. Pregnant women who have congenital heart disease represent the largest number of patients seen at some referral centers, comprising as many as 70% to 80% of all the cardiac patients. It is estimated ...
Early detection of heart failure
... in the future, real medical costs of heart disease and HF are projected to increase by about 200 % between 2010 and 2030.9 HF is associated with high morbidity and mortality. One in five patients die within one year of diagnosis, with sudden cardiac death occurring at six to nine times the rate of t ...
... in the future, real medical costs of heart disease and HF are projected to increase by about 200 % between 2010 and 2030.9 HF is associated with high morbidity and mortality. One in five patients die within one year of diagnosis, with sudden cardiac death occurring at six to nine times the rate of t ...
G-0967 Coronary Heart Disease, Myocardial
... • Death of cells in the myocardium, usually related to prolonged or severe ischemia • Necrosis, tissue damage, and sometimes death results • Cause of MI include: ̶ Sudden onset of ventricular fibrillation ̶ Embolus (most common cause) ̶ Thrombosis ̶ Atherosclerotic occlusion ̶ Prolonged vasospasm ...
... • Death of cells in the myocardium, usually related to prolonged or severe ischemia • Necrosis, tissue damage, and sometimes death results • Cause of MI include: ̶ Sudden onset of ventricular fibrillation ̶ Embolus (most common cause) ̶ Thrombosis ̶ Atherosclerotic occlusion ̶ Prolonged vasospasm ...
European multicentre validation study of the accuracy of E/e ratio in
... because of ascertained or suspected coronary artery disease. Each laboratory will be requested to recruit patients with and without heart failure (according to the 2012 ESC guidelines),21 and their history and clinical status at the time of enrolment will be recorded. Each laboratory will be request ...
... because of ascertained or suspected coronary artery disease. Each laboratory will be requested to recruit patients with and without heart failure (according to the 2012 ESC guidelines),21 and their history and clinical status at the time of enrolment will be recorded. Each laboratory will be request ...
Lecture 3
... Ischemic Heart Disease Myocardial infarction • The severity or duration of ischemia is enough to cause cardiac muscle death. • Typically results from acute thromboses that ...
... Ischemic Heart Disease Myocardial infarction • The severity or duration of ischemia is enough to cause cardiac muscle death. • Typically results from acute thromboses that ...
Automated External Defibrillator
... algorithm to distinguish ventricular fibrillation (VF) from other cardiac rhythms, advise the rescuer that a shockable rhythm is present, and then allow for the delivery of the appropriate amplitude shock to "restart" the individual's heart. Policy and Coverage Criteria: Automated external defibrill ...
... algorithm to distinguish ventricular fibrillation (VF) from other cardiac rhythms, advise the rescuer that a shockable rhythm is present, and then allow for the delivery of the appropriate amplitude shock to "restart" the individual's heart. Policy and Coverage Criteria: Automated external defibrill ...
Click here for handout
... thoracentesis and clinically improved • He was scheduled to have an aortic valve and root replacement and discharged 11/11/09 root replacement and discharged 11/11/09. ...
... thoracentesis and clinically improved • He was scheduled to have an aortic valve and root replacement and discharged 11/11/09 root replacement and discharged 11/11/09. ...
Cardiac contractility modulation
.jpg?width=300)
Cardiac contractility modulation (CCM) is a treatment for patients with moderate to severe left ventricular systolic heart failure (NYHA class II–IV). The short- and long-term use of this therapy enhances both the strength of ventricular contraction and the heart’s pumping capacity. The CCM mechanism is based on stimulation of the cardiac muscle by non-excitatory electrical signals (NES). CCM treatment is delivered by a pacemaker-like device that applies the NES, adjusted to and synchronized with the electrical action in the cardiac cycle.In CCM therapy, electrical stimulation is applied to the cardiac muscle during the absolute refractory period. In this phase of the cardiac cycle, electrical signals cannot trigger new cardiac muscle contractions, hence this type of stimulation is known as a non-excitatory stimulation. However, the electrical CCM signals increase the influx of calcium ions into the cardiac muscle cells (cardiomyocytes). In contrast to other electrical stimulation treatments for heart failure, such as pacemaker therapy or implantable cardioverter defibrillators (ICD), CCM does not affect the cardiac rhythm directly. Rather, the aim is to enhance the heart’s natural contraction (the native cardiac contractility) sustainably over long periods of time. Furthermore, unlike most interventions that increase cardiac contractility, CCM is not associated with an unfavorable increase in oxygen demand by the heart (measured in terms of Myocardial Oxygen Consumption or MVO2). This may be explained by the beneficial effect CCM has in improving cardiac efficiency. A meta-analysis in 2014 and an overview of device-based treatment options in heart failure in 2013 concluded that CCM treatment is safe, that it is generally beneficial to patients and that CCM treatment increases the exercise tolerance (ET) and quality of life (QoL) of patients. Furthermore, preliminary long-term survival data shows that CCM is associated with lower long-term mortality in heart failure patients when compared with expected rates among similar patients not treated with CCM.